| 000 | 01015 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250514073639.0 | ||
| 264 | 0 | _c20040409 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a1568-0118 | ||
| 024 | 7 |
_a10.2174/1568011033482305 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aClassen, Johannes | |
| 245 | 0 | 0 |
_aAntiangiogenesis and radiotherapy: what is the role of combined modality treatment? _h[electronic resource] |
| 260 |
_bCurrent medicinal chemistry. Anti-cancer agents _cSep 2003 |
||
| 300 |
_a375-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xdrug therapy |
| 700 | 1 | _aBudach, Wilfried | |
| 773 | 0 |
_tCurrent medicinal chemistry. Anti-cancer agents _gvol. 3 _gno. 5 _gp. 375-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1568011033482305 _zAvailable from publisher's website |
| 999 |
_c12648645 _d12648645 |
||